Structure-based peptide inhibitors of p53 aggregation as a new approach to cancer therapeutics
This invention relates, eg, to an inhibitory peptide or CPP inhibitor which specifically binds to
p53 having an aberrant conformation (eg, is aggregated or misfolded) and inhibits p53 …
p53 having an aberrant conformation (eg, is aggregated or misfolded) and inhibits p53 …
Cell-permeable stapled peptide modules for cellular delivery
2020-08-17 Assigned to DANA-FARBER CANCER INSTITUTE, INC. reassignment DANA-
FARBER CANCER INSTITUTE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
FARBER CANCER INSTITUTE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE …